Join Growin Stock Community!
Beta
Back to FMS.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
revenue-chart

FMS Revenue

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

Fresenius medical care ag & co. kgaa (FMS) 2026Q1 financial report shows revenue of 4.61B EUR, with a YoY growth rate of -5.52%. Although revenue has slightly decreased compared to the same period last year, reflecting changes in industry demand, the company’s operations remain relatively stable. To fully assess Fresenius medical care ag & co. kgaa (FMS)’s potential risks and future development, investors should continue to monitor subsequent financial reports and strategic adjustments, and use diversified data analysis, including Growin AI Value Analysis, for a prudent and comprehensive evaluation.